Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-1.25 %
$ 76.1 M
Market Cap
-0.76
P/E
INZY - FREE CASH FLOW
Free Cash Flow INZY - Inozyme Pharma, Inc.
-71 M
LAST VALUE
-20.91%
2 YEAR CAGR
-48.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR